| | |
MedLine Citation:
|
PMID: 14707578 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Reversible myocardial depression in sepsis has been ascribed to the release of inflammatory mediators. We recently found that lysozyme c (Lzm-S), consistent with that originating from the spleen, was a mediator of myocardial depression in an Escherichia coli model of septic shock in dogs. We further showed in a right ventricular trabecular (RVT) preparation that Lzm-S's depressant activity could be blocked by N,N',N" triacetylglucosamine (TAC), a competitive inhibitor of Lzm-S. We hypothesized that Lzm-S binds to or cleaves a cardiac membrane glycoprotein, thereby interfering with myocardial contraction in sepsis. In the present study, we examined whether TAC could prevent myocardial depression in an in vivo preparation and whether other related N-acetylglucosamine (NAG) structures could also inhibit Lzm-S's effect in RVT. DESIGN: Randomized experimental study. SETTING: University laboratory. SUBJECTS: Anesthetized, mechanically ventilated dogs. INTERVENTIONS: We produced sepsis by infusion of E. coli over an approximately 6-hr period. MEASUREMENTS AND MAIN RESULTS: We examined the effect of TAC on stroke work, our primary index of myocardial function, when treatment was administered before sepsis (pretreatment) and after 1.5 hrs (early treatment study) and 3.5 hrs of sepsis (late treatment study; LTS). In the pretreatment study and early treatment study, myocardial depression would have not yet occurred but would have already been present in the late treatment study. In RVT, we assessed the effect of other NAG oligosaccharides and variants to the NAG structure on Lzm-S's depressant activity. In pretreatment and the early treatment study, TAC prevented the reduction in stroke work observed in nontreated septic groups but did not reverse the reduction found in the late treatment study. In RVT, of the compounds tested, only N,N'-diacetylglucosamine showed an inhibitory effect. CONCLUSIONS: We found that TAC, a competitive inhibitor of Lzm-S, prevented myocardial depression in experimental sepsis. Only specific NAG structures are inhibitory to Lzm-S's depressant activity. TAC may be useful in attenuating cardiovascular collapse in sepsis. |
| | |
Authors:
|
Steven N Mink; Hans Jacobs; Krika Duke; Deepak Bose; Zhao-Qin Cheng; R Bruce Light |
Related Documents
:
|
14678138 - Optical mapping of transmural activation induced by electrical shocks in isolated left ... 7049098 - Circulatory assistance with a cardiac allograft after exclusion of the canine left vent... 6708298 - Prolonged veno-arterial bypass with membrane oxygenator for profound cardiogenic shock ... 19713678 - Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. 21287278 - Utility of nonspecific resting electrocardiographic features for detection of coronary ... 16787808 - Sudden onset of paraplegia from acute aortic occlusion: a review of 2 cases and their u... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Critical care medicine Volume: 32 ISSN: 0090-3493 ISO Abbreviation: Crit. Care Med. Publication Date: 2004 Jan |
Date Detail:
|
Created Date: 2004-01-06 Completed Date: 2004-02-12 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0355501 Medline TA: Crit Care Med Country: United States |
Other Details:
|
Languages: eng Pagination: 184-93 Citation Subset: AIM; IM |
Affiliation:
|
Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg. minksn@cc.umanitoba.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylglucosaminidase
/
pharmacology* Animals Cardiac Output / drug effects* Disease Models, Animal Dogs Escherichia coli Infections / drug therapy* Female Male Muramidase / drug effects, metabolism* Myocardial Contraction / drug effects Myocardial Depressant Factor / analysis Probability Random Allocation Reference Values Sensitivity and Specificity Shock, Septic / drug therapy* Stroke Volume / drug effects Ventricular Dysfunction, Left / prevention & control* |
| Chemical | |
Reg. No./Substance:
|
0/Myocardial Depressant Factor; EC 3.2.1.17/Muramidase; EC 3.2.1.52/Acetylglucosaminidase |
| Comments/Corrections | |
Comment In:
|
Crit Care Med. 2004 Jan;32(1):304-5
[PMID:
14707605
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cocaine enhances susceptibility to endotoxemic shock in a subset of rats.
Next Document: Arginine vasopressin compromises gut mucosal microcirculation in septic rats.